AI-Powered CRISPR-Cas9: Precision Therapeutics for ATP7B Mutations in Wilson Disease and Restoring Copper Metabolism. CDF [Internet]. 2025 Feb. 20 [cited 2025 Sep. 11];54(4):667-83. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/2032